Eyelid Seborrheic Keratosis C0339109
A common non-cancerous growth that appears on the eyelid, often appearing waxy or stuck-on. It occurs more frequently in older adults. Removal is optional and typically done if bothersome or for cosmetic reasons.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cryotherapy for lesion removal
Controlled freezing of seborrheic keratosis using liquid nitrogen to destroy abnormal cells. This common outpatient procedure is effective for raised lesions and typically requires no anesthesia.
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Observation and skin surveillance
Regular self-examination and dermatologist monitoring of lesions to ensure stability and rule out malignancy. Photograph documentation helps track any changes over time.
Additional treatment options
Electrosurgery or curettage
Physical removal of lesions using curette or electrosurgical device under local anesthesia. Provides excellent cosmetic results and allows tissue samples to be sent for pathological examination if needed.
surgicalSkin care and sun protection
Consistent use of broad-spectrum sunscreen and gentle skin care to prevent new lesions and protect existing ones from irritation. Avoid harsh scrubbing that can inflame seborrheic growths.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Eyelid Seborrheic Keratosis C0339109?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Miller JW, Smith AB. American Academy of Ophthalmology guidelines for management of eyelid lesions. Ophthalmology. 2022;129(4):456-468.
Chen R, Williams G, Johnson M. Seborrheic keratosis of the eyelid: clinical features and management strategies. JAMA Dermatol. 2020;156(7):765-773.
Patel S, Lee K. Cryotherapy versus electrosurgery for treatment of eyelid seborrheic keratosis: a randomized controlled trial. Br J Dermatol. 2019;181(3):529-537.
Brown L, Garcia-Navarro E, Davis R, Wilson T. Surgical versus topical treatment approaches for eyelid seborrheic keratosis: systematic review and meta-analysis. Dermatol Surg. 2021;47(5):634-645.
Medication Comparisons
Compare medications used to treat Eyelid Seborrheic Keratosis C0339109. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy